CMPI.org

In the News

It’s time to get serious about the economics of expanded access

01/30/2019 12:00 AM | STAT

Health sharing, a viable option for health care

01/08/2019 12:00 AM | The Washington Times

Elizabeth Warren's Threat to Medical Progress

01/06/2019 12:00 AM | RealClearHealth

HHS Drug Price Plan Is a Gift to Global ‘Freeloaders’

12/27/2018 12:00 AM | RealClearHealth

Zeroing Out Drug Prices

12/17/2018 12:00 AM | Morning Consult

Keeping the government out of Medicare Part D

12/04/2018 12:00 AM | The Washington Times

FDA and Juul E-Cig Regs Should Keep Anti-Smoking Zealots at Bay

11/16/2018 12:00 AM | RealClearHealth

Streamline drug approval process

11/11/2018 12:00 AM | Echo Press

‘Transparency’ alone can’t convey the context or complexity of pricing drugs

11/06/2018 12:00 AM | The Washington Times

Medicines regulation in the MENA region and the importance of the World Health Organization’s INN proposal of Biological Qualifier

11/02/2018 12:00 AM | Generics and Biosimilars Initiative Journal

War on Vaping Threatens Public Health

09/21/2018 12:00 AM | Real Clear Policy

PBMs Are Hogging Our Drug Discounts

08/28/2018 12:00 AM | Fortune

Safe Harbor Sunshine And Flat Fees: Vital Steps Towards Smarter Drug Spending

08/17/2018 12:00 AM | Health Affairs

Big Brother Wants Your Genes

07/19/2018 12:00 AM | Investor's Business Daily

The E-Cigarette ban will increase smoking and kill more Israelis

07/19/2018 12:00 AM | The Jerusalem Post

A high-stakes exam for healthcare leadership

07/17/2018 12:00 AM | Washington Examiner

President Trump attacks symptom, not disease, in prescription drug price attack

07/10/2018 12:00 AM | The Hill

'It's the health care ecosystem, Stupid'

06/04/2018 12:00 AM | The Washington Times

Trump's Plan To Bring Down Drug Prices Is Winner

05/31/2018 12:00 AM | Investor's Business Daily

More Generics Aren't A Prescription Drug Cost Silver Bullet

05/26/2018 12:00 AM | The Daily Caller

Previous
1
...
5
6
7
8
9
10
11
Next

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

The Journal of Clinical Investigation
08/17/2026 12:00 AM

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

CMPI
08/10/2026 12:00 AM

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

CMPI
02/03/2026 12:00 AM

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more

Read all News